Alterations in the Salivary Proteome and N-Glycome of Sjögren's Syndrome Patients.

We used isobaric mass tagging (iTRAQ) and lectin affinity capture mass spectrometry (MS)-based workflows for global analyses of parotid saliva (PS) and whole saliva (WS) samples obtained from patients diagnosed with primary Sjögren's Syndrome (pSS) who were enrolled in the Sjögren's International Collaborative Clinical Alliance (SICCA) as compared with two control groups. The iTRAQ analyses revealed up- and down-regulation of numerous proteins that could be involved in the disease process (e.g., histones) or attempts to mitigate the ensuing damage (e.g., bactericidal/permeability increasing fold containing family (BPIF) members). An immunoblot approach applied to independent sample sets confirmed the pSS associated up-regulation of β2-microglobulin (in PS) and down-regulation of carbonic anhydrase VI (in WS) and BPIFB2 (in PS). Beyond the proteome, we profiled the N-glycosites of pSS and control samples. They were enriched for glycopeptides using lectins Aleuria aurantia and wheat germ agglutinin, which recognize fucose and sialic acid/N-acetyl glucosamine, respectively. MS analyses showed that pSS is associated with increased N-glycosylation of numerous salivary glycoproteins in PS and WS. The observed alterations of the salivary proteome and N-glycome could be used as pSS biomarkers enabling easier and earlier detection of this syndrome while lending potential new insights into the disease process.

[1]  Caitlin P. McHugh,et al.  Genome‐Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry , 2017, Arthritis & rheumatology.

[2]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.

[3]  G. Leoni,et al.  Annexin A1: shifting the balance towards resolution and repair , 2016, Biological chemistry.

[4]  Mototsugu Nagao,et al.  Association of psoriasis with Hashimoto's thyroiditis, Sjögren's syndrome and dermatomyositis , 2016, The Journal of dermatology.

[5]  N. Karlsson,et al.  Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness* , 2015, Molecular & Cellular Proteomics.

[6]  S. Fisher,et al.  Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation , 2015, Clinical Proteomics.

[7]  P. Veith,et al.  Gingival crevicular fluid proteomes in health, gingivitis and chronic periodontitis. , 2015, Journal of periodontal research.

[8]  Jin Lin,et al.  Biomarkers for Primary Sjögren’s Syndrome , 2015, Genom. Proteom. Bioinform..

[9]  Chi‐Huey Wong,et al.  Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis. , 2015, Journal of the American Chemical Society.

[10]  D. Wong,et al.  Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion. , 2015, Rheumatology.

[11]  Kamran Nazmi,et al.  Histatin‐1, a histidine‐rich peptide in human saliva, promotes cell‐substrate and cell‐cell adhesion , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  L. Criswell,et al.  The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome , 2015, Annals of the rheumatic diseases.

[13]  A. Vissink,et al.  Ig Gene Analysis Reveals Altered Selective Pressures on Ig-Producing Cells in Parotid Glands of Primary Sjögren’s Syndrome Patients , 2015, The Journal of Immunology.

[14]  L. Borradori,et al.  Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. , 2014, The Journal of investigative dermatology.

[15]  Uroš Andjelković,et al.  Isolation, biochemical characterization and anti-bacterial activity of BPIFA2 protein. , 2014, Archives of oral biology.

[16]  D. Spieler,et al.  Acute transverse myelitis and psoriasiform dermatitis associated with Sjoegren’s syndrome: a case report , 2014, BMC Research Notes.

[17]  S. Knudsen,et al.  Unique protein signature of circulating microparticles in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[18]  W. Kuo,et al.  Diagnostic model of saliva peptide finger print analysis of primary Sjögren's syndrome patients by using weak cation exchange magnetic beads , 2013, Bioscience reports.

[19]  L. Herrinton,et al.  The association of psoriasis with autoimmune diseases. , 2012, Journal of the American Academy of Dermatology.

[20]  M. Aslan,et al.  Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome. , 2012, Clinical and experimental rheumatology.

[21]  M. Gucek,et al.  Quantitative proteomics of parotid saliva in primary Sjögren's syndrome , 2012, Proteomics.

[22]  P. Vlachoyiannopoulos,et al.  Subgroups of Sjögren syndrome patients according to serological profiles. , 2012, Journal of autoimmunity.

[23]  L. Criswell,et al.  Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry , 2012, Arthritis care & research.

[24]  Hua Xiao,et al.  Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry. , 2012, Analytica chimica acta.

[25]  Y. Matsuo,et al.  Extremely high salivary β2‐microglobulin and Na+ levels in a Sjögren syndrome patient , 2012, International journal of rheumatic diseases.

[26]  L. Criswell,et al.  American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort , 2012, Arthritis care & research.

[27]  W. Haddon,et al.  Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics. , 2012, Journal of oral science.

[28]  J. Pers,et al.  In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. , 2012, Autoimmunity reviews.

[29]  Sean L. Seymour,et al.  CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes. , 2012, Journal of proteomics.

[30]  S. Bombardieri,et al.  Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes , 2011, Arthritis research & therapy.

[31]  S. Bombardieri,et al.  Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report , 2011, Journal of Translational Medicine.

[32]  M. Aslan,et al.  Polymorphism in the TNF-alpha Gene Promoter is Associated With Increased Circulating Levels of TNF-alpha, Myeloperoxidase and Nitrotyrosine in Primary Sjogren's Syndrome , 2011 .

[33]  L. Bingle,et al.  Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family. , 2011, Biochemical Society transactions.

[34]  Ruth L. Seal,et al.  Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. , 2011, Biochemical Society transactions.

[35]  L. Bingle,et al.  Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. , 2011, Biochemical Society transactions.

[36]  L. Punzi,et al.  Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. , 2011, Autoimmunity reviews.

[37]  A. Vissink,et al.  Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays , 2011, Proteomics.

[38]  Dylan J. Sorensen,et al.  A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma. , 2011, Analytical biochemistry.

[39]  J. Duarte,et al.  Salivary peptidomics , 2010, Expert review of proteomics.

[40]  C. Fanali,et al.  Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. , 2010, Autoimmunity reviews.

[41]  Y Wu,et al.  Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. , 2009, Journal of periodontal research.

[42]  A I Bolstad,et al.  The minor salivary gland proteome in Sjögren's syndrome. , 2009, Oral diseases.

[43]  S. Cross,et al.  Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein , 2009, Histochemistry and Cell Biology.

[44]  L. Criswell,et al.  An early view of the international Sjögren's syndrome registry. , 2009, Arthritis and rheumatism.

[45]  D. Wong,et al.  Salivary Diagnostics , 2019, Saliva and Salivary Diagnostics.

[46]  Y. Fleissig,et al.  Different proteomic protein patterns in saliva of Sjögren's syndrome patients. , 2009, Oral diseases.

[47]  A. Vissink,et al.  Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. , 2009, Arthritis and rheumatism.

[48]  D. Wong,et al.  Glycoprofiling of the Human Salivary Proteome , 2009, Clinical Proteomics.

[49]  John R Yates,et al.  The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. , 2008, Journal of proteome research.

[50]  S. Cha,et al.  Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome , 2008, Rheumatology International.

[51]  S. Bombardieri,et al.  Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? , 2008, Autoimmunity reviews.

[52]  F. Watt,et al.  Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier , 2007, The Journal of cell biology.

[53]  A. Vissink,et al.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[54]  C. Fanali,et al.  Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. , 2007, Arthritis and rheumatism.

[55]  Chiara Baldini,et al.  Proteome analysis of whole saliva: A new tool for rheumatic diseases – the example of Sjögren's syndrome , 2007, Proteomics.

[56]  P. Fox Autoimmune Diseases and Sjögren's Syndrome , 2007, Annals of the New York Academy of Sciences.

[57]  D. Waisman,et al.  Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. , 2007, The Journal of general virology.

[58]  G. Illei,et al.  Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. , 2006, Rheumatology.

[59]  W. Ens,et al.  Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis. , 2006, Analytical chemistry.

[60]  Joseph A Loo,et al.  Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. , 2006, Journal of proteome research.

[61]  X. Mariette,et al.  Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome , 2005 .

[62]  T. Witte Antifodrin Antibodies in Sjögren's Syndrome: A Review , 2005, Annals of the New York Academy of Sciences.

[63]  S. Klebanoff Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[64]  M. Takiguchi,et al.  Autoimmunity against a Tissue Kallikrein in IQI/Jic Mice , 2005, Journal of Biological Chemistry.

[65]  E. Ben-Chetrit,et al.  Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome , 1993, Clinical Rheumatology.

[66]  X. Mariette,et al.  Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome. , 2005, Annals of the rheumatic diseases.

[67]  I. Bhattacharyya,et al.  Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjo˝gren's syndrome: a preliminary study , 2004, Scandinavian journal of rheumatology.

[68]  R. Gay,et al.  Galectin 3 and its binding protein in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[69]  J. Sabio,et al.  Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[70]  S. Gorr,et al.  Expression and anti-bacterial activity of human parotid secretory protein (PSP). , 2003, Biochemical Society transactions.

[71]  M. Paul-Clark,et al.  The FASEB Journal express article 10.1096/fj.02-0239fje. Published online December 3, 2002. Aberrant inflammation and resistance to glucocorticoids in Annexin 1 –/ – Mouse , 2022 .

[72]  C. Vitali Classification criteria for Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.

[73]  R. Jonsson,et al.  Genetic aspects of Sjögren's syndrome , 2002, Arthritis research.

[74]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.

[75]  Z. Dlamini,et al.  Kallikrein and Kinin Receptor Expression in Inflammation and Cancer , 2001, Biological chemistry.

[76]  P. Pizcueta,et al.  Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome , 2000, Annals of the rheumatic diseases.

[77]  Jamin,et al.  Increased N‐Linked Glycosylation Leading to Oversialylation of Monomeric Immunoglobulin A1 from Patients with Sjögren's Syndrome , 2000, Scandinavian journal of immunology.

[78]  S. Parkkila,et al.  Salivary carbonic anhydrase isoenzyme VI , 1999, The Journal of physiology.

[79]  E. Donadi,et al.  Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome. , 1998, The Journal of rheumatology.

[80]  A. Silman,et al.  Sjögren's syndrome: a community-based study of prevalence and impact. , 1998, British journal of rheumatology.

[81]  A. Burlingame,et al.  Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity. , 1998, Biochemistry.

[82]  R. Timpl,et al.  Mac‐2 binding protein is a cell‐adhesive protein of the extracellular matrix which self‐assembles into ring‐like structures and binds β1 integrins, collagens and fibronectin , 1998, The EMBO journal.

[83]  G. Ciliberto,et al.  Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coli. , 1993, European journal of biochemistry.

[84]  A. Linde,et al.  Salivary kallikrein in Sjögren's syndrome. , 1988, Clinical and experimental rheumatology.

[85]  D. Proud,et al.  Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.

[86]  M. Levine,et al.  Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva. , 1987, Archives of biochemistry and biophysics.

[87]  Y. Yang,et al.  The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. , 1986, The Journal of biological chemistry.

[88]  J. Jenzano,et al.  Evaluation of kallikrein in human parotid and submandibular saliva. , 1986, Archives of oral biology.

[89]  L. Tabak,et al.  Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular-sublingual saliva. , 1982, Carbohydrate research.

[90]  H. Grey,et al.  Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. , 1975, The New England journal of medicine.

[91]  J. J. Bunim,et al.  SJÖGREN'S SYNDROME: A Clinical, Pathological, and Serological Study of Sixty-two Cases , 1965, Medicine.